Background: Enucleation of pancreatic neuroendocrine tumours (pNETs) via robotic surgery has rarely been described. This study sought to assess the safety and efficiency of robotic surgery for the enucleation of small pNETs. 
Introduction
Pancreatic neuroendocrine tumours (pNETs) have an incidence of 0⋅43 per 100 000 individuals and constitute 1-2 per cent of all pancreatic neoplasms 1 . Surgical resection currently represents the only curative option. The approach varies among patients owing to the heterogeneous clinical features and potential invasiveness of pNETs. Simple enucleation is usually recommended for insulinomas and small non-functional pNETs smaller than 2 cm in diameter and distant from the main pancreatic duct 1, 2 , despite controversy regarding the indication for surveillance of such small non-functional pNETs 3 . Improved techniques for tumour localization have increased the accuracy of open surgery, which is still the predominant approach for pNET enucleation. However, the development of minimally invasive surgery has made it possible to avoid large incisions for small tumours 4 .
Minimally invasive surgery has shown advantages in terms of shorter hospital stay, reduced blood loss, and equivalent rates of complications compared with the open technique 2 . Laparoscopic surgery has traditionally focused on surgical resections for pNETs of the pancreatic body and tail. Few studies have reported on laparoscopic resection of the pancreatic head and uncinate process, owing to the complex retroperitoneal anatomy and safety concerns.
Robotic surgery has made a more refined form of surgery possible and expanded the indication for minimally invasive surgery 5 -8 . Zureikat and colleagues 9 have reported a large series of 250 robot-assisted pancreatic operations, most of which were distal pancreatectomies or pancreaticoduodenectomies. Robotic surgery for pNET enucleation has rarely been described, and the safety and efficiency of this technique remain unclear.
The authors' centre has applied a robotic platform for pancreatic surgery in selected patients since 2012. This study reviewed a propensity score-matched cohort of patients with pNET, who underwent enucleation via open or robotic surgery. The role of robotic surgery for enucleation was evaluated by comparing safety-related outcomes, such as postoperative pancreatic fistula (POPF) rates, estimated blood loss (EBL) and major complications, and efficiency-related outcomes, such as duration of surgery and postoperative length of hospital stay (LOS) between the two groups.
Methods

Study design and patient enrolment
This retrospective study included patients undergoing enucleation for pNETs via robotic surgery between September 2012 and May 2015. Patients who had robotic surgery were registered in a prospective clinical database, and robotic surgery for pNETs started in September 2012. All patients who received open or robotic surgical enucleation for pathologically confirmed pNETs were identified from a medical record-based database at a single institution from January 2000 to May 2015. All investigators were trained in standard criteria and procedures during data collection.
Inclusion and exclusion criteria
Inclusion criteria were: preoperative diagnosis of resectable benign pNET, enucleation as the intended surgical procedure, maximum diameter no more than 2 cm by pathological examination of the specimen, distance between tumour and main pancreatic duct greater than 2 mm on preoperative or intraoperative imaging, and no evidence of pancreatic duct dilatation. Exclusion criteria were: maximum pNET diameter of more than 2 cm, multiple pNETs or ectopic lesions, a history of previous pancreatic resection, procedures synchronous with enucleation (such as cholecystectomy), distant metastasis, pancreatitis, pancreatic adenocarcinoma, or severe cardiac or pulmonary disease. The study was approved by the local ethics committee. All patients provided written informed consent.
Diagnosis and surgery
The diagnosis of a functional pNET was made by combining clinical symptoms and laboratory evidence 10 . A 72-h fasting test was considered the standard for diagnosis of insulinoma. Abdominal multislice contrast-enhanced spiral CT, MRI, somatostatin receptor scintigraphy and/or endoscopic ultrasonography were used to determine tumour location, diagnose pNET, and decide on the surgical approach. A 68 Ga-labelled PET-CT scan was conducted for patients with a suspected pancreatic tumour but in whom the above examinations did not provide conclusive information. All examinations were double-checked by two specialists.
Using the DaVinci ® Surgical System (Intuitive Surgical, Sunnyvale, California, USA), one surgeon conducted all robotic procedures. Six experienced surgeons performed the open procedures. The technical details of enucleation via open surgery have been described elsewhere 11 . In robotic surgery, exposure of the pancreas was achieved by separation and traction of the gastrocolic and gastropancreatic ligaments by robotic arms, and intraoperative ultrasonography was employed to localize multiple lesions, lesions that were deep in the parenchyma, or lesions close to the pancreatic duct. After precise localization, the superficial pancreatic tissue was cut to expose the pseudocapsule of the tumour. A cross-stitch through the tumour was made routinely and then held by one robotic arm. Thus, the tumour could be pulled in any direction. Separation was subsequently carried out along the margin of the tumour with the Harmonic ® scalpel (Ethicon Endo-Surgery, Cincinnati, Ohio, USA); although not endowristed, the separation process could be completed precisely. Interrupted stitches were commonly applied for haemostasis after tumour removal. Prophylactic antibiotics were administered 30 min before skin incision. Intraoperative frozen sectioning was performed routinely to confirm the diagnosis. An intra-abdominal drain was left in all patients. Octreotide analogues such as somatostatin (Merck Serono, Aubonne, Switzerland) or Sandostatin ® (Novartis Pharma, Stein, Switzerland) were used as standard prophylaxis for POPF formation.
Main outcome measures
The primary outcome was POPF rate, which refers to grade B and grade C fistula. Other safety-related variables included intraoperative EBL, conversion rate to open surgery, major postoperative complications, and all-cause 30-and 90-day mortality. Duration of surgery and LOS were considered as efficiency-related variables. 
Sample size estimation
The main outcome of the study was the rate of grade B and C pancreatic fistula, and the number of patients needed to reach statistical significance was based on this. The type I error was set at 0⋅05, and the type II error at 0⋅20 (statistical power 0⋅8). Based on the literature, pancreatic fistula grade B/C rates for open pancreatic surgery were estimated as 13 per cent 14, 15 and those for robotic surgery as 27 per cent 16 . A 'non-inferiority test' was used to estimate sample size. The equivalence margin, δ, was estimated based on several meta-analyses 14, 15, 17 . Overall, a δ value of 5 per cent was a conservative estimation of no significant difference between the two groups. Therefore, with 1 : 1 matching, there should be approximately 53 patients in each group 18 : 
Statistical analysis
Propensity score matching and all statistical analyses were done using SPSS ® version 20.0 (IBM, Armonk, New York, USA). Categorical variables are shown as frequencies and percentages, and continuous variables are expressed as median (range) or mean(s.d.) after testing for normality. Mann-Whitney U test or Student's t test was used for continuous variables, and categorical variables were analysed by means of χ 2 and Fisher's exact test. P < 0⋅050 was considered statistically significant.
Results
A total of 522 patients with pNETs underwent surgery during the study period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) , of whom 187 (35⋅8 per cent) had enucleation via the open approach and 61 (11⋅7 per cent) by the robotic approach. One patient in the robotic group (simultaneous pNET enucleation and liver cyst resection) and 85 in the open group (33 underwent simultaneous procedures such as cholecystectomy or liver cyst resection; 5 patients with multiple endocrine neoplasia type 1 had parathyroid resection during the same hospital stay; 47 had pNETs larger than 2 cm) were excluded. Some 162 patients were selected according to the inclusion and exclusion criteria before matching. After propensity score matching, a balanced cohort was created with the robotic group as the observational group (60 patients) and the open group (60) as control.
The study population contained 38 men (31⋅7 per cent) and 82 women (68⋅3 per cent). There were no differences in baseline data (sex, age, BMI) or clinical features (symptoms, tumour location and size) ( Table 1 ). All lesions were enucleated completely. According to the Ki-67 index and mitotic rate, most pNETs were classified as grade 1 (72 per cent in the open group and 83 per cent in the robotic group). With regard to hypoglycaemic symptoms and blood sugar results, the majority of pNET lesions were diagnosed as insulinomas (97 and 93 per cent respectively) and the rest as non-functional pNETs.
Intraoperative and postoperative outcomes
The overall rate of POPF was 13⋅3 per cent (16 of 120) ( Table 2) , with rates of 17 and 10 per cent in the open and robotic group respectively (P = 0⋅283). The 30-day mortality rate was zero in both groups, but one patient in the open group died from septic shock 88 days after operation, giving a 90-day mortality rate of 2 per cent for the open group (Table 3) . Intraoperative median EBL was lower in the robotic group (32⋅5 ml versus 80⋅0 ml in the open group; P = 0⋅008). One patient in each group required blood transfusion during surgery. Three patients (5 per cent) in the robotic group required conversion to open surgery, because of failure to progress or haemorrhage.
Major postoperative complications tended to occur more frequently in the open group than in the robotic group (10 versus 3 per cent respectively; P = 0⋅272). There were five grade III complications in the open group (2 cases of delayed gastric emptying healed conservatively, 3 abdominal infections treated by antibiotics and drainage). The patient in the open group with the grade V complication suffered from severe pancreatic fistula, abdominal infection (methicillin-resistant Staphylococcus aureus), bowel leakage after reoperation and wound infection, and died in the intensive care unit. In the robotic group, two patients had grade III complications (1 abdominal haemorrhage treated conservatively, 1 case of delayed gastric emptying).
The median duration of surgery was shorter in the robotic group than in the open group (117 (mean 135) versus 150 min respectively; P < 0⋅001) ( Table 3 ). The median postoperative LOS tended to be shorter in the robotic group (12⋅0 versus 13⋅5 days respectively; P = 0⋅071).
Discussion
Robotic surgery has shown encouraging results in selected patients in procedures such as distal pancreatectomy, central pancreatectomy, Frey's procedure and pancreaticoduodenectomy 9, 19, 20 . Few data have been reported on pNET enucleation. Enucleation has been reported to be safe and effective for the treatment of benign and borderline pancreatic tumours by either the open or laparoscopic approach 21, 22 . However, the safety and efficiency of enucleation using the robotic approach is currently unknown. The present study reports on 60 consecutive patients with pNET enucleated via a robotic approach at a single institution, compared with 60 historical open pNET enucleations using propensity score matching. The assumption regarding robotic surgery was that the technical advantages of a robotic system for pNET enucleation might improve surgical safety and efficiency.
In this study, the robotic approach was associated with a reduced duration of surgery, less intraoperative blood loss, and a tendency to a lower POPF rate and grade III-V complications compared with open surgery. These findings are consistent with a study reported by Shi and colleagues 16 , who compared 26 patients undergoing robotic enucleation with 17 having an open operation, and showed reduced operating time and blood loss. However, tumour characteristics were not balanced between the groups before surgery, which might have affected surgical difficulty.
Duration of surgery was shorter in the robotic group in the present study, and the mean time of 135 min compares favourably with that of 206 min for ten robotically enucleated cases described by Zureikat and co-workers 9 . Factors contributing to shorter operating time include surgeon experience, uncomplicated surgical procedure, haemorrhage control, BMI and tumour location. In the present study, all robotic procedures were performed by one surgeon, whereas open procedures were carried out by different surgeons. All surgeons were dedicated and high-volume pancreatic surgeons, helping to lessen the degree of bias. On the other hand, the robotic platform provided three-dimensional visualization, which combined with the endowrist technique made traction, separation and suturing easier. This facilitated meticulous vascular control and pancreas mobilization, probably contributing to the reduced operating time in the robotic arm. The reduced EBL in the robotic group is in keeping with this, and was lower than reported EBL values for laparoscopic enucleations (median 300-500 ml) 23 . The conversion rate of 5 per cent in the robotic group was comparable with published data 22 . Enucleation via robotic surgery seems safe and efficient. Overall morbidity in the robotic group was similar to that for laparoscopic pancreatic resections 24 , and compares favourably with that found in previous studies of robotic enucleation 9, 25 .
POPF was the most common complication in the present study of enucleation of small pNETs. As reported in the literature 2, 26, 27 , enucleation tends to cause a higher rate of POPF than distal pancreatectomy or pancreaticoduodenectomy. The overall POPF rate in the present cohort was similar to previously published data from the authors' institution 11 , but lower than the 23⋅0-27⋅4 per cent reported by others 21, 28 . In the robotic group, the POPF rate was lower than reported previously 16 , and tended to be lower than for open surgery. Polanco et al. 29 and Fu and colleagues 30 both found that higher EBL and smaller pancreatic duct diameter were associated with a higher POPF rate, based on robotic and open pancreaticoduodenectomies. In addition, male sex and operating time over 180 min were independent determinants of grade B/C POPF 31 . In the present study there was no difference in major complications between the two groups, or in 30-or 90-day mortality, supporting the safety of the robotic approach.
The reduced operating time and blood loss, and the relatively low morbidity rate might have resulted in a reduced postoperative LOS in the robotic group, but there was no difference in LOS between the two groups. LOS was longer in the present study than the median of 5 days reported from Western countries 9 , perhaps because of the conservative approach to dealing with the drainage tube. In the authors' institution, the drainage tube is preferentially removed before the patient is discharged, as complications that occur outside the hospital are reimbursed only partially.
This study has several limitations. There is the inherent bias of any retrospective study, although propensity score matching was conducted to minimize bias. In addition, because robotic surgery had been introduced only recently, the study focused mainly on short-term outcomes. Results of long-term follow-up are awaited to determine recurrence rates and other clinical events, such as endocrine insufficiency.
